text: 图11-1AML治疗计划○HA或DA；◎大剂量Ara-c+柔红霉素；●大剂量Ara-c+VP-16；◇HA|鞘注化疗Ara-c1mg/kg，MTX12.5mg/m2</sup>（最大12.5mg），DX5mg；A组包括M1、M2、M3、M6、M7，B组为M4、M5全反式维A酸对M3</sub>有效，可诱导其分化成熟，约60%～70%病人在单用维A酸后可获得缓解，但如不加用化疗，仍复发。
entities.entity: AML
entities.label: dis
entities.entity: Ara-c
entities.label: dru
entities.entity: 柔红霉素
entities.label: dru
entities.entity: Ara-c
entities.label: dru
entities.entity: VP-16
entities.label: dru
entities.entity: 鞘注化疗
entities.label: pro
entities.entity: Ara-c
entities.label: dru
entities.entity: 维A酸
entities.label: dru
entities.entity: 维A酸
entities.label: dru
entities.entity: 化疗
entities.label: pro